• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Cardiogenic Shock (2262)
Event Date 07/22/2022
Event Type  Death  
Event Description
It was reported that during an implant, the surgeon noted some bleeding which was believed to be coming from the inflow cannula/ mini apical cuff interface.The patient had a preoperative platelet count of 81 that indicated there could be surgical bleeding.The bleeding was improved, chest was closed and the patient was transferred to the intensive care unit (icu).The patient was returned to the operating room (or) twice for chest exploration for bleeding but cardiothoracic surgery only needle hole bleeding.The patient went into cardiogenic shock that led to multisystem organ failure.In the evening of (b)(6) 2022,the family made a do not resuscitate (dnr) and the patient expired.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Manufacturer Narrative
Section h6: health effect - clinical code: multiple organ dysfunction syndrome (3261).Manufacturer's investigation conclusion: no device-related issues were identified during evaluation of heartmate 3 lvas, (b)(6).The reported bleeding between the interface of the pump and the apical cuff could not be confirmed as no images were submitted for review, and a direct cause for the reported event was unable to be determined through this evaluation.A direct relationship between the pump and the reported bleeding, cardiogenic shock, multi organ failure, and patient outcome could not be conclusively determined through this evaluation.(b)(6)w as returned assembled with the pump cable severed approximately 20 inches from the pump header and the distal segment was not returned.The modular cable was not returned.The sealed outflow graft attachment was returned attached to the pump cover outlet port.The sealed outflow graft bend relief was returned attached to the graft hardware.The cuff lock was fully engaged, and the mini apical cuff was returned attached to the cuff lock.Upon disassembly of the returned pump, examination of the blood-contacting surfaces revealed no adhered depositions or thrombus formations that would have contributed to a flow or functional issue.Visual inspection of the pump rotor and rotor well did not reveal any obvious surface scratches or defects.Examination of the cuff lock found no evidence of defect or damage.Dimensional analysis of the cuff lock arms, apical sealing ring, motor cap, and the mini cuff found the components to be within manufacturing specification.The cuff lock and apical sealing ring were reassembled, and the mini apical cuff was connected and engaged without issue.The lvad event and periodic log files retrieved from the returned device appeared to capture the device functioning as intended.(b)(6) was cleaned, rebuilt, and functionally tested on a mock circulatory loop.The device operated as intended and in accordance with manufacturing specifications the relevant sections of the device history records were reviewed, including the cuff lock installation and inspection, and showed no deviations from manufacturing or quality assurance specifications.Review of the lvad assembly device history records showed that the cuff lock installed on (b)(6) passed all inspection and testing.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu) is currently available.The ifu lists bleeding, multiple organ failures, and death as adverse events that may be associated with the use of the heartmate 3 lvas.The ifu provides instructions on all surgical procedures, including preparing the ventricular apex site and inserting the pump in the ventricle.The ifu cautions that after the mini apical cuff has been sewn to the heart, the metal ring on the mini apical cuff should extend above the felt surface to allow proper engagement and locking with the slide lock of the heartmate 3 lvad.If the slide lock mechanism on the heartmate 3 lvad fails to engage, do not make further attempts to engage until retracting the slide lock mechanism.Evidence of slide lock mechanism failing to engage will be either visual evidence of the yellow ¿wings¿ or a tactile feel of three ridges versus one.The slide lock will not engage the mini apical cuff unless initially fully retracted.If difficulty persists when engaging the slide lock mechanism, the lvad should be removed from the mini apical cuff to visualize what might be preventing the connection.The suture knots should not interfere with the connection.If a sealing agent is used on or near the mini apical cuff, it should not interfere with the slide lock mechanism.The surgical procedures section also includes information on de-airing the pump.During the implant process, a complete backup system (implant kit and external components) must be available on-site and in close proximity for use in an emergency.No further information was provided.The manufacturer is closing the file on this event.
 
Manufacturer Narrative
No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key15133208
MDR Text Key296908175
Report Number2916596-2022-12615
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date03/12/2024
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number8495403
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/28/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/27/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Death;
Patient Age66 YR
Patient SexMale
Patient Weight88 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-